Vulnerability identifier: #VU26245

Vulnerability risk: Low

CVSSv3.1: 6.7 [CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L/E:U/RL:U/RC:C]

CVE-ID: CVE-2020-10597

CWE-ID: CWE-284

Exploitation vector: Local

Exploit availability: No

Vulnerable software:
Omnipod Insulin Management System
Client/Desktop applications / Other client software

Vendor: Insulet Corporation

Description

The vulnerability allows a local attacker to gain unauthorized access to otherwise restricted functionality.

The vulnerability exists due to improper access restrictions in the wireless RF communication protocol. A local attacker with access to one of the affected insulin pump models can bypass implemented security restrictions and modify and/or intercept data.

The vulnerability can also allow attackers to change pump settings and control insulin delivery.

This vulnerability affects the following versions of the Omnipod Insulin Management System:

Product ID/Reorder number: 19191 and 40160

UDI/Model/NDC number: ZXP425 (10-Pack) and ZXR425 (10-Pack Canada)

Mitigation
Cybersecurity Help is currently unaware of any official solution to address this vulnerability.

Vulnerable software versions

Omnipod Insulin Management System: All versions

---

External links
http://ics-cert.us-cert.gov/advisories/icsma-20-079-01

---

Q & A

Can this vulnerability be exploited remotely?

No. This vulnerability can be exploited locally. The attacker should have authentication credentials and successfully authenticate on the system.

Is there known malware, which exploits this vulnerability?

No. We are not aware of malware exploiting this vulnerability.